Capital Flow Monitor · Sponsors · CIK 2008210

NexPoint Life Sciences III DST

300 CRESCENT COURT, DALLAS, TX, 75201 · (833) 697-6246

Other Real Estate · Other· inc. DELAWARE true 2023

Fit score

52

  • pct_sold>=75+18
  • filed<=4mo+12
  • placement_agent+12
  • investors 61-150+6
  • people+4

Offering

$30.7M

Sold

$28.0M

% sold

91.2%

Investors

92

Min investment

$100K

Exemption

506(c)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-08-11 D/A ·current 506(c) $30.7M $28.0M 91.2% 92 EDGAR ↗
2026-01-13 D/A 506(c) $30.7M $25.2M 82.1% 81 EDGAR ↗
2025-08-06 D/A 506(c) $30.7M $14.2M 46.2% 59 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.